CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 124 filers reported holding CARDLYTICS INC in Q4 2022. The put-call ratio across all filers is 1.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $378 | +98.9% | 22,907 | -23.6% | 0.00% | – |
Q2 2023 | $190 | +91.9% | 29,982 | +3.5% | 0.00% | – |
Q1 2023 | $99 | -23.3% | 28,977 | +29.5% | 0.00% | – |
Q4 2022 | $129 | -99.9% | 22,377 | -1.6% | 0.00% | – |
Q3 2022 | $214,000 | -45.4% | 22,750 | +29.4% | 0.00% | – |
Q2 2022 | $392,000 | -56.5% | 17,580 | +7.2% | 0.00% | – |
Q1 2022 | $901,000 | -10.9% | 16,396 | +7.1% | 0.00% | – |
Q4 2021 | $1,011,000 | -23.6% | 15,304 | -2.9% | 0.00% | – |
Q3 2021 | $1,324,000 | -29.6% | 15,768 | +6.4% | 0.00% | – |
Q2 2021 | $1,881,000 | +12.5% | 14,823 | -2.8% | 0.00% | – |
Q1 2021 | $1,672,000 | -7.9% | 15,246 | +19.9% | 0.00% | – |
Q4 2020 | $1,816,000 | +173.1% | 12,718 | +35.0% | 0.00% | – |
Q3 2020 | $665,000 | -11.2% | 9,419 | -12.0% | 0.00% | – |
Q2 2020 | $749,000 | -32.8% | 10,698 | -84.1% | 0.00% | – |
Q1 2019 | $1,114,000 | +167.1% | 67,379 | +74.9% | 0.00% | – |
Q4 2018 | $417,000 | -91.3% | 38,533 | -80.0% | 0.00% | -100.0% |
Q3 2018 | $4,817,000 | – | 192,380 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
Cannell Capital | 626,975 | $16,289,000 | 4.62% |
Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |